This funding opportunity will build on the respective research strengths of Canada and Japan through the Japan Agency for Medical Research and Development (AMED) and CIHR, in basic science and technology as it relates to epigenetics and epigenomics.
Each jointly planned Canada-Japan project will receive a maximum award of $300,000 CAD from CIHR for the Canadian component of the team, plus 30 million JPY from AMED for the Japanese researchers over a three-year period (that is $100,000 CAD from CIHR plus 10 million JPY from AMED per year over three years).
Application Deadline: September 15, 2020
Applications must be received in the Office of Research a minimum of 5 business days in advance of the application deadline. Applications must be submitted to the Office of Research via Romeo. Please allow enough time for Chair and Dean approval.